Incidence and risk factors for pneumonitis among patients with lung cancer who received immune checkpoint inhibitors after palliative thoracic radiotherapy

The aim of this study is to analyze the incidence and risk factors for pneumonitis when immune checkpoint inhibitors (ICIs) are combined with palliative thoracic radiotherapy (RT) for lung cancer. We retrospectively evaluated 29 patients with lung cancer who received ICIs after palliative thoracic R...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Satoshi, Abe, Takanori, Iino, Misaki, Aoshika, Tomomi, Ryuno, Yasuhiro, Ohta, Tomohiro, Igari, Mitsunobu, Hirai, Ryuta, Kumazaki, Yu, Yamaguchi, Ou, Kaira, Kyoichi, Kagamu, Hiroshi, Noda, Shin-ei, Kato, Shingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Oncology/Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273801/
https://www.ncbi.nlm.nih.gov/pubmed/34121123
http://dx.doi.org/10.1093/jrr/rrab051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273801/
https://www.ncbi.nlm.nih.gov/pubmed/34121123
http://dx.doi.org/10.1093/jrr/rrab051

Ejemplares similares